Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) Additional Paid-In Capital : $6,445.06 Mil(As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ginkgo Bioworks Holdings Additional Paid-In Capital?

Ginkgo Bioworks Holdings's quarterly additional paid-in capital increased from Sep. 2023 ($6,334.22 Mil) to Dec. 2023 ($6,386.00 Mil) and increased from Dec. 2023 ($6,386.00 Mil) to Mar. 2024 ($6,445.06 Mil).

Ginkgo Bioworks Holdings's annual additional paid-in capital increased from Dec. 2021 ($3,804.84 Mil) to Dec. 2022 ($6,136.38 Mil) and increased from Dec. 2022 ($6,136.38 Mil) to Dec. 2023 ($6,386.00 Mil).

Ginkgo Bioworks Holdings Additional Paid-In Capital Historical Data

The historical data trend for Ginkgo Bioworks Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ginkgo Bioworks Holdings Additional Paid-In Capital Chart

Ginkgo Bioworks Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

929.13

3,804.84

6,136.38

6,386.00

Ginkgo Bioworks Holdings Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial											6,211.63	6,280.63	6,334.22	6,386.00	6,445.06

Ginkgo Bioworks Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Ginkgo Bioworks Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Ginkgo Bioworks Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ginkgo Bioworks Holdings Inc (NYSE:DNA.WS) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

DNA:USA DNA:Mexico

Address

27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210

Website

https://www.ginkgobioworks.com

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Foundry and Biosecurity. The Biosecurity segment generates the majority of revenue.